CN113142394A - Feed additive, feed and preparation method and application thereof - Google Patents
Feed additive, feed and preparation method and application thereof Download PDFInfo
- Publication number
- CN113142394A CN113142394A CN202110276229.8A CN202110276229A CN113142394A CN 113142394 A CN113142394 A CN 113142394A CN 202110276229 A CN202110276229 A CN 202110276229A CN 113142394 A CN113142394 A CN 113142394A
- Authority
- CN
- China
- Prior art keywords
- feed
- parts
- dha
- feed additive
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003674 animal food additive Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 9
- 241000187481 Mycobacterium phlei Species 0.000 claims abstract description 24
- 229940055036 mycobacterium phlei Drugs 0.000 claims abstract description 22
- 241000003595 Aurantiochytrium limacinum Species 0.000 claims abstract description 18
- 235000010208 anthocyanin Nutrition 0.000 claims abstract description 16
- 229930002877 anthocyanin Natural products 0.000 claims abstract description 16
- 239000004410 anthocyanin Substances 0.000 claims abstract description 16
- 150000004636 anthocyanins Chemical class 0.000 claims abstract description 16
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims abstract description 15
- 235000019743 Choline chloride Nutrition 0.000 claims abstract description 15
- 229960003178 choline chloride Drugs 0.000 claims abstract description 15
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 241000233671 Schizochytrium Species 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 14
- 238000004108 freeze drying Methods 0.000 claims description 9
- 108090000145 Bacillolysin Proteins 0.000 claims description 6
- 108091005658 Basic proteases Proteins 0.000 claims description 6
- 108091005507 Neutral proteases Proteins 0.000 claims description 6
- 102000035092 Neutral proteases Human genes 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 239000004519 grease Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 235000019764 Soybean Meal Nutrition 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 2
- 239000004455 soybean meal Substances 0.000 claims description 2
- 235000013601 eggs Nutrition 0.000 abstract description 37
- 241000287828 Gallus gallus Species 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 142
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 72
- 229940090949 docosahexaenoic acid Drugs 0.000 description 70
- 239000003921 oil Substances 0.000 description 35
- 235000019198 oils Nutrition 0.000 description 35
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 17
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 17
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 17
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 17
- 102000002322 Egg Proteins Human genes 0.000 description 9
- 108010000912 Egg Proteins Proteins 0.000 description 9
- 241000195493 Cryptophyta Species 0.000 description 8
- 210000002969 egg yolk Anatomy 0.000 description 8
- 235000013345 egg yolk Nutrition 0.000 description 8
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 8
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 6
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 5
- 235000013330 chicken meat Nutrition 0.000 description 5
- 229960004488 linolenic acid Drugs 0.000 description 5
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 5
- 235000021323 fish oil Nutrition 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 125000004494 ethyl ester group Chemical group 0.000 description 3
- 239000000413 hydrolysate Substances 0.000 description 3
- 235000021388 linseed oil Nutrition 0.000 description 3
- 239000000944 linseed oil Substances 0.000 description 3
- 238000000464 low-speed centrifugation Methods 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- ZUUFLXSNVWQOJW-MBIXAETLSA-N (2e,4e,6e)-octadeca-2,4,6-trienoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C(O)=O ZUUFLXSNVWQOJW-MBIXAETLSA-N 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 2
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- -1 are eggs rich in DHA Chemical compound 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000001328 optic nerve Anatomy 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000012202 endocytosis Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000008604 lipoprotein metabolism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- JBXYCUKPDAAYAS-UHFFFAOYSA-N methanol;trifluoroborane Chemical compound OC.FB(F)F JBXYCUKPDAAYAS-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003988 neural development Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035921 thrombopoiesis Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Feed For Specific Animals (AREA)
Abstract
The application provides a feed additive, a feed, and a preparation method and application thereof. The feed additive comprises the following components in parts by weight: 6-9 parts of schizochytrium limacinum oil, 1-4 parts of mycobacterium phlei, 1-3 parts of anthocyanin and 1-4 parts of choline chloride. Feed, including basal feed and feed additives. The preparation method of the feed comprises the following steps: mixing the basic feed with feed additive. The application of the feed is used for feeding hens. The feed additive provided by the application extracts DHA oil from schizochytrium limacinum, strengthens the absorption and conversion of DHA in a chicken body by using mycobacterium phlei and choline chloride, utilizes anthocyanin to be efficient and antioxidant, and finally achieves the purpose of efficiently and highly-pure enriching DHA in eggs.
Description
Technical Field
The application relates to the field of feeds, in particular to a feed additive, a feed, and a preparation method and application thereof.
Background
The DHA eggs are eggs rich in DHA, and the chemical name of the DHA is docosahexaenoic acid, which is a polyunsaturated fatty acid very important for human bodies. DHA is a main element for the growth and maintenance of nervous system cells, is an important component of brain and retina, and has three main functions: (1) promoting brain neural development; (2) promoting development of optic nerve; (3) improving immunity. As the channel for supplementing DHA is single, a large amount of DHA can be obtained only by eating seafood products, and the fish oil capsule products have low digestibility, the DHA is enriched into eggs, so that the channel for obtaining DHA by people is high-efficiency.
The DHA in the eggs mainly exists in the form of lecithin type DHA, and is different from artificially purified DHA and DHA in natural fish oil or algae oil, the artificially purified DHA is usually ethyl ester type DHA, namely ethanol plus DHA, and the ethanol is commonly called as alcohol, so that some people allergic to the alcohol, especially pregnant women and women in lactation period, are not suitable for eating the ethyl ester type DHA. Natural DHA is often "triglyceride-type" DHA, which has a much lower digestibility than the "lecithin-type DHA in eggs. The egg is known as "whole nutrient food", and DHA egg still contains other essential nutrients in addition to being rich in DHA: such as protein, mineral, vitamin and rich long-chain unsaturated fatty acid, break the mode of single-purity DHA supplement in the health care product. DHA is enriched in eggs, so that the daily required DHA can be supplemented more comprehensively, safely and conveniently by the public, and the DHA-enriched egg has important significance for improving the health of human beings.
Although the DHA content of a lot of omega-3 rich eggs in the market is high, due to the fact that the eggs contain a large amount of linolenic acid and EPA, the DHA purity (particularly the content proportion of DHA in omega-3 unsaturated fatty acid) is low, so that a lot of challenges exist in the process of enriching DHA in the eggs: (1) because DHA belongs to long-chain unsaturated fatty acid, the conversion efficiency of the chicken group into DHA through octadecatrienoic acid (ALA, linolenic acid) is very low, so that the DHA-related additives (such as linseed and the like) are not preferable to be fed; (2) if fish oil or linseed oil with high DHA content is fed, a certain amount of EPA (eicosapentaenoic acid) (ALA) and eicosapentaenoic acid (EPA) can be produced by the body due to the fact that the EPA is rich, and the EPA can expand blood vessels, but the problems of thrombopoiesis obstacle and the like can be caused by excessive consumption of the eggs by infants, so the eggs with high EPA content are not suitable for children and pregnant women; (3) even if the feed for the chickens does not contain ALA and EPA, the organism has very limited digestion and absorption rate of DHA; (4) in addition, because unsaturated fatty acid is easily oxidized in the body, the DHA enrichment efficiency in eggs is difficult to guarantee.
In view of this, the present application is specifically made.
Disclosure of Invention
The present application aims to provide a feed additive, a feed, a preparation method and an application thereof, so as to solve the above problems.
In order to achieve the purpose, the following technical scheme is adopted in the application:
a feed additive comprises the following components in parts by weight:
6-9 parts of schizochytrium limacinum oil, 1-4 parts of mycobacterium phlei, 1-3 parts of anthocyanin and 1-4 parts of choline chloride.
The egg yolk in the egg is a precursor of the egg yolk, during the process of enriching the egg yolk by the egg yolk, the egg yolk precursor carries DHA to be combined with a specific receptor on the egg yolk and enters the egg yolk through endocytosis, and during the physiological metabolic process, the DHA enrichment in the egg yolk is influenced by the following 4 aspects: (1) DHA needs to be highly pure in the feed: excessive other fatty acids exist and can form metabolic competition effect with DHA, so that the enrichment of DHA is influenced, and the contents of linolenic acid and EPA are controlled, so that the contents of the two in eggs can be controlled; (2) health degree of intestinal mucosa of chicken organism: the health of the intestinal mucosa is the basis for guaranteeing the digestion and absorption of DHA; (3) the integral oxidation resistance of chicken organism: as DHA belongs to long-chain unsaturated fatty acid, oxidation is easy to occur, and if the organism oxidation resistance of the chicken is not strong, DHA can be consumed in the organism, thereby reducing the DHA enrichment in the eggs; (4) metabolic capacity of liver for lipids: the DHA is enriched in the eggs, mainly through a lipoprotein metabolism path, and the DHA enrichment can be influenced by the strong and weak metabolic capability of the liver on the lipoprotein.
Optionally, in the feed additive, the amount of schizochytrium oil can be any value between 6 parts, 7 parts, 8 parts, 9 parts and 6-9 parts by weight; the amount of Mycobacterium phlei may be any of 1 part, 2 parts, 3 parts, 4 parts and 1-4 parts; the amount of anthocyanins can be any value between 1 part, 2 parts, 3 parts and 1-3 parts; the choline chloride may be used in any amount between 1 part, 2 parts, 3 parts, 4 parts, and 1-4 parts.
Preferably, the feed additive comprises the following components in parts by weight: 6 parts of schizochytrium limacinum oil, 2 parts of mycobacterium phlei, 1 part of anthocyanin and 1 part of choline chloride.
Preferably, the preparation method of the schizochytrium oil comprises the following steps:
and (3) sequentially centrifuging, drying and carrying out enzymolysis on the schizochytrium to obtain the schizochytrium oil.
Preferably, the centrifugal force of the centrifugation is 10000 Xg-12000 Xg, the temperature is 3-5 ℃, and the time is 20-40 min;
preferably, the drying comprises freeze-drying at a temperature of-50 ℃ to-40 ℃ for a period of 18-30 h.
The schizochytrium oil obtained by the method has the DHA purity as high as 40% and the EPA content is low (less than or equal to 0.4%).
Optionally, the centrifugal force of the centrifugation may be any value between 10000 xg, 11000 xg, 12000 xg and 10000 xg-12000 xg, the temperature may be any value between 3 ℃, 4 ℃, 5 ℃ and 3-5 ℃, and the time may be any value between 20min, 30min, 40min and 20-40 min; the temperature of the freeze drying can be any value between-50 ℃, 45 ℃, 40 ℃ and-50 ℃ to-40 ℃, and the time can be any value between 18h, 24h, 30h and 18-30 h.
Preferably, the enzymatic hydrolysis comprises: firstly, carrying out enzymolysis for 2-4h by using neutral protease at the temperature of 40-50 ℃ and under the condition of pH 6-7; then carrying out enzymolysis for 5-7h by using alkaline protease at 65-75 ℃ and under the condition of pH9-10, and then centrifuging and layering to remove upper-layer grease.
Optionally, the temperature for enzymolysis by neutral protease can be any value between 40 ℃, 45 ℃, 50 ℃ and 40-50 ℃, the pH can be any value between 6, 6.5, 7 and 6-7, and the time can be any value between 2h, 3h, 4h and 2-4 h; the temperature for enzymolysis by alkaline protease can be 65 ℃, 70 ℃, 75 ℃ and any value between 65 ℃ and 75 ℃, the pH can be 9, 9.1, 9.2, 9.3, 9.4, 9.5, 9.6, 9.7, 9.8, 9.9, 10 and any value between 9 and 10, and the time can be any value between 5h, 6h, 7h and 5 to 7 h.
Preferably, the mycobacterium phlei species is f.u.36;
preferably, the Mycobacterium phlei is inactivated for 15-25min at 110-130 ℃ prior to use.
The main effect of inactivation is to reduce the risk of adverse reactions caused by live bacteria.
Optionally, the temperature for inactivating Mycobacterium phlei may be any value between 110 ℃, 120 ℃, 130 ℃ and 110-.
The application also provides a feed, which comprises a basic feed and the feed additive.
Preferably, the feed additive accounts for 0.5-0.7% of the total mass of the feed.
Alternatively, the proportion of the feed additive to the total mass of the feed may be any value between 0.5%, 0.6%, 0.7% and 0.5-0.7%.
Preferably, the basal feed comprises one or more of corn, soybean meal and premix.
The premix referred to in this application may be any commonly used feed additive that is premixed. The following premix is preferably used: protein is taken as a carrier, and each kilogram of the protein provides the following contents of minerals and vitamins, namely 150mg of Fe, Cu: 20mg, Zn 150mg, Mn 30mg, Se 0.4mg, I0.3 mg, VA 17800IU, VD 35000IU, VE 44IU, VK 5mg, VB 18mg, VB2 15mg, VB6 8.5mg, VB12 0.05mg, VB3 60mg, VB5 25mg and VB9 2.5 mg.
The application also provides a preparation method of the feed, which comprises the following steps:
mixing the basal feed and the feed additive.
The application also provides an application of the feed for feeding hens.
Compared with the prior art, the beneficial effect of this application includes:
the feed additive and the feed provided by the application realize high-purity DHA purification by extracting DHA oil from schizochytrium limacinum, and the mycobacterium phlei is used for improving the digestive absorption rate of the intestinal tract (improving the nonspecific immunity of the intestinal tract mucous membrane, thereby ensuring the health of the intestinal tract mucous membrane and further achieving the purpose of efficiently absorbing DHA, if the health of the intestinal tract cannot be ensured, the absorption and the utilization of any nutrient elements cannot be mentioned at all), choline chloride is used for strengthening lipid metabolism, anthocyanin is used for efficiently resisting oxidation, and finally the purpose of efficiently and highly purifying enriched DHA of eggs is achieved, under the condition of improving the DHA content in eggs, the ALA and EPA contents are very low, the problem that alcohol allergy people generated by ethyl ester type DHA are not applicable is avoided, the egg is suitable for pregnant women, lactating women and children of low age to eat, and the egg has important significance on the development of cranial nerves and the development of optic nerves of fetuses and infants;
the preparation method of the feed is simple in process.
Drawings
To more clearly illustrate the technical solutions of the embodiments of the present application, the drawings that are required to be used in the embodiments are briefly described below, and it should be understood that the following drawings only illustrate some embodiments of the present application and therefore should not be considered as limiting the scope of the present application.
FIG. 1 is a photograph of Schizochytrium oil obtained in example 1;
FIG. 2 is a photograph of the feed obtained in example 1;
figure 3 is a photograph of feeding with the feed provided herein.
Detailed Description
The terms as used herein:
"prepared from … …" is synonymous with "comprising". The terms "comprises," "comprising," "includes," "including," "has," "having," "contains," "containing," or any other variation thereof, as used herein, are intended to cover a non-exclusive inclusion. For example, a composition, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, process, method, article, or apparatus.
The conjunction "consisting of … …" excludes any unspecified elements, steps or components. If used in a claim, the phrase is intended to claim as closed, meaning that it does not contain materials other than those described, except for the conventional impurities associated therewith. When the phrase "consisting of … …" appears in a clause of the subject matter of the claims rather than immediately after the subject matter, it defines only the elements described in the clause; other elements are not excluded from the claims as a whole.
When an amount, concentration, or other value or parameter is expressed as a range, preferred range, or as a range of upper preferable values and lower preferable values, this is to be understood as specifically disclosing all ranges formed from any pair of any upper range limit or preferred value and any lower range limit or preferred value, regardless of whether ranges are separately disclosed. For example, when the range "1 ~ 5" is disclosed, the ranges described should be construed to include the ranges "1 ~ 4", "1 ~ 3", "1 ~ 2 and 4 ~ 5", "1 ~ 3 and 5", and the like. When a range of values is described herein, unless otherwise stated, the range is intended to include the endpoints thereof and all integers and fractions within the range.
In these examples, the parts and percentages are by mass unless otherwise indicated.
"part by mass" means a basic unit of measure indicating a mass ratio of a plurality of components, and 1 part may represent any unit mass, for example, 1g or 2.689 g. If we say that the part by mass of the component A is a part by mass and the part by mass of the component B is B part by mass, the ratio of the part by mass of the component A to the part by mass of the component B is a: b. alternatively, the mass of the A component is aK and the mass of the B component is bK (K is an arbitrary number, and represents a multiple factor). It is unmistakable that, unlike the parts by mass, the sum of the parts by mass of all the components is not limited to 100 parts.
"and/or" is used to indicate that one or both of the illustrated conditions may occur, e.g., a and/or B includes (a and B) and (a or B).
Embodiments of the present application will be described in detail below with reference to specific examples, but those skilled in the art will appreciate that the following examples are only illustrative of the present application and should not be construed as limiting the scope of the present application. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.
Example 1
The embodiment provides a feed additive, which comprises the following components in parts by weight: 6 parts of schizochytrium limacinum oil, 2 parts of mycobacterium phlei, 1 part of anthocyanin and 1 part of choline chloride.
Wherein, the schizochytrium oil is prepared by fresh schizochytrium through low-speed centrifugation, freeze drying and two-step enzymolysis method in turn, and the detailed steps are as follows: (1) centrifuging at 11200 Xg centrifugal force and 4 deg.C for 30min with a low speed centrifuge; (2) removing supernatant after centrifugation, freeze-drying the residual algae mud for 24h at-45 ℃, and crushing to form dry powder; (3) performing two-step enzymolysis treatment, wherein in the first step, 7% of neutral protease is added, the pH value is adjusted to pH 6.5, the enzymolysis time is 3 hours at the temperature of 45 ℃, in the second step, 10% of alkaline protease is added, the pH value is adjusted to pH 9.4, and the enzymolysis time is 6 hours at the temperature of 68 ℃; (4) and (3) taking out the enzymatic hydrolysate after the enzymolysis is finished, centrifuging for 10min at 5000rpm, layering, and taking out the upper layer of grease, namely the purified schizochytrium oil (as shown in figure 1). The oil content of the schizochytrium limacinum oil is more than or equal to 90 percent and the DHA content is more than or equal to 40 percent. The strain of Mycobacterium phlei is F.U.36, and is inactivated at 120 deg.C for 20min before use.
The laying period of the laying hens is based on the basic feed, and the feed additive is added according to 0.6% of the total weight of the feed to obtain the feed (shown in figure 2), and the feed is mixed and fed (shown in figure 3). The obtained egg has an octadecatrienoic acid (ALA) content of less than or equal to 40mg/100g, an eicosapentaenoic acid (EPA) content of less than or equal to 15mg/100g, and a docosahexaenoic acid (DHA) content of greater than or equal to 150mg/100 g.
Example 2
The embodiment provides a feed additive, which comprises the following components in parts by weight: 6.5 parts of schizochytrium limacinum oil, 3 parts of mycobacterium phlei, 2 parts of anthocyanin and 3 parts of choline chloride.
Wherein, the schizochytrium oil is prepared by fresh schizochytrium through low-speed centrifugation, freeze drying and two-step enzymolysis method in turn, and the detailed steps are as follows: (1) centrifuging at a centrifugal force of 10000 Xg and a temperature of 3 ℃ for 40min by using a low-speed centrifuge; (2) removing supernatant after centrifugation, freeze-drying the residual algae mud at-50 ℃ for 30h, and crushing to form dry powder; (3) performing two-step enzymolysis treatment, wherein in the first step, neutral protease is added by 7%, the pH value is adjusted to pH6, and the enzymolysis is performed for 4 hours at the temperature of 40 ℃, and in the second step, alkaline protease is added by 10%, the pH value is adjusted to pH9, and the enzymolysis is performed for 7 hours at the temperature of 65 ℃; (4) and taking out the enzymatic hydrolysate after the enzymolysis is finished, centrifuging for 10min at 5000rpm, layering, and taking out the upper layer of grease, namely the purified schizochytrium oil. The oil content of the schizochytrium limacinum oil is more than or equal to 90 percent and the DHA content is more than or equal to 40 percent. The strain of Mycobacterium phlei is F.U.36, and is inactivated at 110 deg.C for 25min before use.
The feed additive is added into the laying hens in the laying period according to 0.5% of the total weight of the feed on the basis of the basic feed, and the laying hens are mixed and fed.
Example 3
The embodiment provides a feed additive, which comprises the following components in parts by weight: 9 parts of schizochytrium limacinum oil, 4 parts of mycobacterium phlei, 3 parts of anthocyanin and 4 parts of choline chloride.
Wherein, the schizochytrium oil is prepared by fresh schizochytrium through low-speed centrifugation, freeze drying and two-step enzymolysis method in turn, and the detailed steps are as follows: (1) centrifuging at 12000 Xg centrifugal force and 5 deg.C for 20min with low speed centrifuge; (2) removing supernatant after centrifugation, freeze-drying the residual algae mud at-40 deg.C for 18h, and pulverizing to obtain dry powder; (3) performing two-step enzymolysis treatment, namely adding 7% of neutral protease in the first step, adjusting the pH value to pH 7, performing enzymolysis for 3 hours at the temperature of 50 ℃, adding 10% of alkaline protease in the second step, adjusting the pH value to pH10, and performing enzymolysis for 5 hours at the temperature of 75 ℃; (4) and taking out the enzymatic hydrolysate after the enzymolysis is finished, centrifuging for 10min at 5000rpm, layering, and taking out the upper layer of grease, namely the purified schizochytrium oil. The oil content of the schizochytrium limacinum oil is more than or equal to 90 percent and the DHA content is more than or equal to 40 percent. Mycobacterium phlei strain is F.U.36, and is inactivated at 130 deg.C for 15min before use.
The feed additive is added into the laying hens in the laying period according to 0.7% of the total weight of the feed on the basis of the basic feed, and the laying hens are mixed and fed.
Comparative example 1
The basal feed was recorded as group C1 without any feed additives as a blank control.
Comparative example 2
1.2 wt% of tuna oil (product number: CAS:8016-13-5) was added to the basal feed as a feed (DHA content in the feed was 0.15%), and the feed was designated as group C2.
Comparative example 3
2 wt% of linseed oil (product number: CAS:8001-26-1) was added to the basal feed as a feed, and recorded as group C3.
Comparative example 4
0.3 wt% of schizochytrium limacinum oil is added on the basis of the basic feed to be used as feed, and the feed is recorded as T1 group.
Comparative example 5
0.3 wt% of schizochytrium limacinum oil, 0.15 wt% of mycobacterium phlei and 0.1 wt% of choline chloride are added on the basis of the basic feed, and the feed is marked as T2 group.
Comparative example 6
0.3 wt% of schizochytrium limacinum oil, 0.05 wt% of anthocyanin and 0.1 wt% of choline chloride are added on the basis of the basic feed, and the feed is marked as T3 group.
Comparative example 7
0.3 wt% of schizochytrium limacinum oil, 0.15 wt% of mycobacterium phlei and 0.05 wt% of anthocyanin are added on the basis of the basic feed, and the mixture is marked as T4 group.
Test examples
0.3 wt% of schizochytrium limacinum oil, 0.15 wt% of mycobacterium phlei, 0.05 wt% of anthocyanin and 0.1 wt% of choline chloride are added on the basis of the basic feed, and the feed is marked as T5 group.
Measurement indexes are as follows: removing shell of ovum gallus Domesticus, mixing, and detecting omega-3 unsaturated fatty acid (alpha linolenic acid, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) with index of 2 g.
Summary of omega-3 unsaturated fatty acid detection:
the detection method is the gas chromatography for detecting omega-3 polyunsaturated fatty acid in NY/T2068-2011 eggs and egg products by using a gas chromatograph. Brief introduction of the method: hydrolyzing a sample with hydrochloric acid, extracting fat with diethyl ether-petroleum ether, saponifying with potassium hydroxide and methanol, performing methyl esterification with a boron trifluoride-methanol solution to obtain fatty acid methyl ester, separating by a gas chromatographic column, detecting by a hydrogen flame ionization detector, quantifying the peak area of the peak appearance time of each fatty acid by an edible internal standard method, and calculating the content of each component according to a formula.
The results are shown in table 1:
TABLE 1 test results
As shown in table 1, the results show that: (1) the DHA content of common eggs is low, and is only 25.79mg/100 g; (2) the DHA content of the eggs fed with the fish oil is greatly increased, but the EPA content of the eggs is also increased, and the DHA content of the eggs reaches 34.59mg/100 g; (3) the feed is added with 2.00 percent of linseed oil, which can well enrich DHA, so that the DHA content reaches 152.18mg/100g, but the alpha linolenic acid content reaches 388.32mg/100g, thereby greatly reducing the DHA purity and having great influence on the flavor and the nutritional structure of eggs; (4) the DHA content of two combined groups (T2, T3 and T4) which respectively use algae oil to cooperate with mycobacterium phlei, anthocyanin or choline is improved compared with that of algae oil T1, but is slightly lower than that of the group T5; (5) the DHA content of the eggs in the algae oil combination scheme group (0.3% of schizochytrium oil, 0.15% of mycobacterium phlei, 0.05% of anthocyanin and 0.05% of choline chloride) reaches 189.07mg/100g, the DHA content and purity of the eggs are greatly improved compared with those of common eggs, and the DHA content and purity of the eggs are obviously improved compared with those of the rest control group and the treatment group. In conclusion, the algae oil feed additive provided by the invention can be used for efficiently enriching DHA in eggs, and the purity of DHA in the enriched omega-3 unsaturated fatty acid is improved.
Finally, it should be noted that: the above embodiments are only used for illustrating the technical solutions of the present application, and not for limiting the same; although the present application has been described in detail with reference to the foregoing embodiments, it should be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present application.
Moreover, those skilled in the art will appreciate that while some embodiments herein include some features included in other embodiments, rather than other features, combinations of features of different embodiments are meant to be within the scope of the application and form different embodiments. For example, in the claims above, any of the claimed embodiments may be used in any combination. The information disclosed in this background section is only for enhancement of understanding of the general background of the application and should not be taken as an acknowledgement or any form of suggestion that this information forms the prior art already known to a person skilled in the art.
Claims (10)
1. The feed additive is characterized by comprising the following components in parts by weight:
6-9 parts of schizochytrium limacinum oil, 1-4 parts of mycobacterium phlei, 1-3 parts of anthocyanin and 1-4 parts of choline chloride.
2. The feed additive according to claim 1, comprising, in parts by weight: 6 parts of schizochytrium limacinum oil, 2 parts of mycobacterium phlei, 1 part of anthocyanin and 1 part of choline chloride.
3. The feed additive of claim 1, wherein the schizochytrium oil is prepared by a method comprising:
and (3) sequentially centrifuging, drying and carrying out enzymolysis on the schizochytrium to obtain the schizochytrium oil.
4. The feed additive according to claim 3, wherein the centrifugal force of the centrifugation is 10000 Xg-12000 Xg, the temperature is 3-5 ℃, and the time is 20-40 min;
preferably, the drying comprises freeze-drying at a temperature of-50 ℃ to-40 ℃ for a period of 18-30 h.
5. The feed additive of claim 3, wherein the enzymatic hydrolysis comprises: firstly, carrying out enzymolysis for 2-4h by using neutral protease at the temperature of 40-50 ℃ and under the condition of pH 6-7; then carrying out enzymolysis for 5-7h by using alkaline protease at 65-75 ℃ and under the condition of pH9-10, and then centrifuging and layering to remove upper-layer grease.
6. The feed additive of any one of claims 1-5 wherein the Mycobacterium phlei species is F.U.36;
preferably, the Mycobacterium phlei is inactivated for 15-25min at 110-130 ℃ prior to use.
7. A feed comprising a basal feed and a feed additive according to any one of claims 1 to 6.
8. The feed of claim 7, wherein the feed additive comprises 0.5% to 0.7% of the total mass of the feed;
preferably, the basal feed comprises one or more of corn, soybean meal and premix.
9. A method of preparing the feed of claim 7 or 8, comprising:
mixing the basal feed and the feed additive.
10. Use of the feed according to claim 7 or 8 for feeding hens.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110276229.8A CN113142394A (en) | 2021-03-15 | 2021-03-15 | Feed additive, feed and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110276229.8A CN113142394A (en) | 2021-03-15 | 2021-03-15 | Feed additive, feed and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113142394A true CN113142394A (en) | 2021-07-23 |
Family
ID=76887114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110276229.8A Pending CN113142394A (en) | 2021-03-15 | 2021-03-15 | Feed additive, feed and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113142394A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102160604A (en) * | 2011-03-01 | 2011-08-24 | 厦门汇盛生物有限公司 | Schizochytrium aggregatum powder additive and application thereof to seedling cultivation, aquiculture and culture of poultry and livestock |
CN102715382A (en) * | 2012-07-12 | 2012-10-10 | 湖南农业大学 | Feed regulating and controlling agent for producing eggs enriching dehydroacetic acid (DHA) and feed containing feed regulating and controlling agent |
CN103719540A (en) * | 2013-12-26 | 2014-04-16 | 彭厚新 | Feed additive for increasing DHA (docosahexenoic acid) content of poultry eggs |
CN107189848A (en) * | 2017-05-18 | 2017-09-22 | 中国水产科学研究院南海水产研究所 | A kind of method that kettle algae oil fat is split in extraction of highly effective and safe environmental protection |
CN112120124A (en) * | 2020-08-31 | 2020-12-25 | 嘉必优生物技术(武汉)股份有限公司 | Compound microbial feed for efficiently producing DHA (docosahexaenoic acid) eggs |
US20210205385A1 (en) * | 2018-04-04 | 2021-07-08 | Xiamen Huison Biotech Co., Ltd | Use of schizochytrium limacinum and its preparation in improving the quality and yield of animal product |
-
2021
- 2021-03-15 CN CN202110276229.8A patent/CN113142394A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102160604A (en) * | 2011-03-01 | 2011-08-24 | 厦门汇盛生物有限公司 | Schizochytrium aggregatum powder additive and application thereof to seedling cultivation, aquiculture and culture of poultry and livestock |
CN102715382A (en) * | 2012-07-12 | 2012-10-10 | 湖南农业大学 | Feed regulating and controlling agent for producing eggs enriching dehydroacetic acid (DHA) and feed containing feed regulating and controlling agent |
CN103719540A (en) * | 2013-12-26 | 2014-04-16 | 彭厚新 | Feed additive for increasing DHA (docosahexenoic acid) content of poultry eggs |
CN107189848A (en) * | 2017-05-18 | 2017-09-22 | 中国水产科学研究院南海水产研究所 | A kind of method that kettle algae oil fat is split in extraction of highly effective and safe environmental protection |
US20210205385A1 (en) * | 2018-04-04 | 2021-07-08 | Xiamen Huison Biotech Co., Ltd | Use of schizochytrium limacinum and its preparation in improving the quality and yield of animal product |
CN112120124A (en) * | 2020-08-31 | 2020-12-25 | 嘉必优生物技术(武汉)股份有限公司 | Compound microbial feed for efficiently producing DHA (docosahexaenoic acid) eggs |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2116288T5 (en) | Docosahexanoic acid, processes for its production and compounds containing it | |
DE69231793T2 (en) | MICROBIAL OILS AND THEIR USE | |
Wu et al. | Fatty acid composition of Taiwanese human milk | |
CN1875746A (en) | A compound feed for improving meat quality of cultured Litopenaeus. vannamei | |
CN102742669A (en) | Edible blend oil for promoting development of infant brain and nerve cell | |
CN110800871A (en) | Application of schizochytrium limacinum powder in improving DHA content in ruminant milk | |
Zhu et al. | The lipids of slugs and snails: evolution, diet and biosynthesis | |
CN103719540A (en) | Feed additive for increasing DHA (docosahexenoic acid) content of poultry eggs | |
CN111567632A (en) | Dietary fatty acid nutrition balance blend oil and preparation method thereof | |
CN102204594B (en) | DHA (docosahexaenoic acid)-containing grain blend oil and preparation method thereof | |
CN113142394A (en) | Feed additive, feed and preparation method and application thereof | |
CN113974017B (en) | Feed additive for enriching phosphatidylethanolamine type DHA in eggs, and preparation method and application thereof | |
CN109198253A (en) | For producing feed addictive and the application of high DHA content egg | |
CN113261628A (en) | Feed additive for producing eggs rich in phosphatidylcholine DHA and application | |
CN109198297A (en) | A kind of hilsa herring juvenile fish starter diet | |
CN111233727B (en) | Biological preparation method of all-trans free astaxanthin | |
CN112674337A (en) | Application of fucoxanthin and/or fucoxanthin in preparation for improving DHA level of human body | |
CN108077643B (en) | Feed for producing functional lipid-enriched eggs | |
JPS62269649A (en) | Production of vitamin-enriched chicken egg by photosynthetic bacteria | |
CN111567698A (en) | Feed additive, nutrition-enriched feed, utilization method thereof and nutrition-enriched poultry eggs | |
US20210037854A1 (en) | Eggs rich in nutrients of alpha-linolenic acid and dha, breeding method of laying hens, and feed additive | |
AU2019340853A1 (en) | Oil of microorganisms rich in docosahexaenoic acid | |
CN109123180A (en) | Improve the feed formula for laying hen of omega-3 polyunsaturated fatty acids content in egg | |
CN109392831B (en) | Nutrition enhancer for producing DHA-ARA eggs suitable for infants and application | |
CN114258992A (en) | Feed additive and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210723 |
|
RJ01 | Rejection of invention patent application after publication |